Globeflex Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-73,964
Closed -$884K 507
2021
Q1
$884K Hold
73,964
0.16% 211
2020
Q4
$672K Sell
73,964
-27,787
-27% -$215K 0.14% 237
2020
Q3
$620K Buy
101,751
+17,465
+21% +$133K 0.16% 204
2020
Q2
$748K Buy
+84,286
New +$727K 0.19% 193
2017
Q1
Sell
-63,837
Closed -$690K 575
2016
Q4
$690K Sell
63,837
-47,855
-43% -$638K 0.17% 218
2016
Q3
$1.82M Buy
111,692
+74,981
+204% +$1.06M 0.46% 39
2016
Q2
$350K Sell
36,711
-34
-0.1% -$370 0.1% 283
2016
Q1
$516K Hold
36,745
0.14% 227
2015
Q4
$399K Buy
36,745
+28
+0.1% +$253 0.11% 256
2015
Q3
$250K Buy
36,717
+36,598
+30,755% +$283K 0.05% 358
2015
Q2
$1K Sell
119
-40
-25% -$303 ﹤0.01% 474
2015
Q1
$1K Buy
+159
New +$640 ﹤0.01% 485

Other funds holding NPTN

Globeflex Capital's NPTN Position: Q2 2021 in Review

Globeflex Capital sold out of NEOPHOTONICS CORP (NPTN) in Q2 2021, closing a stake of 73,964 shares — an estimated $884K sold.

Globeflex Capital first reported a position in NPTN in Q1 2015 and held it in 12 quarters. The position peaked at $1.82M in Q3 2016. 138 funds tracked by Wall St. Rank hold NPTN as of Q2 2021.

  • Globeflex Capital reported no remaining NEOPHOTONICS CORP position as of Q2 2021 after selling out during the quarter.
  • Globeflex Capital sold 73,964 NEOPHOTONICS CORP shares in Q2 2021, an estimated $884K.
  • Globeflex Capital first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 12 quarters.
  • Globeflex Capital's NEOPHOTONICS CORP position peaked at $1.82M in Q3 2016.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2021.

Based on Globeflex Capital's 13F filing for Q2 2021, filed 12 Aug 2021.